Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.49 - $1.3 $82,173 - $218,010
-167,700 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.39 - $3.92 $47,538 - $134,064
-34,200 Reduced 16.94%
167,700 $233,000
Q4 2021

Feb 14, 2022

BUY
$3.1 - $8.97 $376,960 - $1.09 Million
121,600 Added 151.43%
201,900 $688,000
Q3 2021

Nov 15, 2021

BUY
$8.35 - $16.99 $670,505 - $1.36 Million
80,300 New
80,300 $710,000
Q2 2021

Aug 16, 2021

SELL
$11.59 - $17.73 $197,030 - $301,410
-17,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$12.97 - $34.0 $220,490 - $578,000
17,000 New
17,000 $227,000

Others Institutions Holding AFIB

About Acutus Medical, Inc.


  • Ticker AFIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,370,300
  • Market Cap $1.13M
  • Description
  • Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conv...
More about AFIB
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.